REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

29 Sep 2020 07:00

RNS Number : 3620A
Osirium Technologies PLC
29 September 2020
 

29 September 2020

 

Osirium Technologies plc

("Osirium", "the Group" or "the Company")

 

Interim Results

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity software, announces its unaudited interim results for the six months ended 30 June 2020.

 

Financial highlights

 

· Total recognised revenue increased 35% to £0.70 million (1H 2019: £0.52 million)

 

· Total bookings decreased 25% to £0.77 million (1H 2019: £1.03 million)

o Record first quarter

o Coronavirus delayed customer buying decisions from Q2

o Uptick in new business wins expected in H2

 

· Deferred revenue increased by 15% to £1.43 million (1H 2019: £1.24 million), providing continued visibility over future revenues

 

· Operating loss of £1.57 million (1H 2019: £1.71 million), reflecting the tight cost control measures we introduced in response to the coronavirus

 

· Cash balances at 30 June 2020 of £2.13 million (1H 2019: £0.89 million), increasing to £2.53 million as at 31 July 2020 following receipt of a £0.56 million R&D tax credit

 

Operational highlights

 

· Swift and effective adaptation to the pandemic with no impact on operational efficiency

· New customers signed across both the private and public sector including one of the UK's largest NHS trusts and a major regional UK ambulance service

 

· Continued illustration of successful 'land and expand' strategy

o 100% renewals across customer base during H1

o Consistent pattern of existing customers booking more in 1H 2020 vs 1H 2019

 

· Ongoing product innovation, with all three products undergoing new releases

 

· Significant growth in our reseller network, establishing presence in Benelux, the Nordics, South-eastern Europe and the Middle East

 

Post period highlights

 

· New contracts signed with a group of major UK police forces, a leading UK university, a regional provider of services to the NHS, an Information Technology and Services consultancy in Indonesia, and an IT solutions provider in the Middle East

 

· Strong response by existing customers to the launch of the Osirium Customer Network, a forum for exchanging experiences and best practices with Osirium technology, with the first three workshops fully booked up

 

· Launch of PPA Express, a free version of the Privileged Process Automation platform to seed new sales opportunities

 

Current trading and outlook

 

While the impact of the coronavirus on the timing of new customer buying decisions means revenue for FY2020 may be lower than current market estimates, the strength of our offering and our growing pipeline provide a strong platform and give us confidence that, assuming the heightened level of uncertainty caused by the virus continues to subside, we will see an uptick in new business wins in the second half and increased revenue growth in FY2021.

 

David Guyatt, CEO of Osirium, commented:

 

"We continued to make good progress against our stated strategy in the period, built around a commitment to innovation, customer focus and market expansion. The coronavirus temporarily slowed new customer acquisition after a record Q1, but market trends continue to move in our favour. We now have a comprehensive and complementary suite of products designed to capitalise on the opportunity, and our pipeline continues to grow.

 

"Moving forwards, we remain focused on delivering our strategic objectives. Management will continue to closely monitor both the financial and operational effects of pandemic on the business, remaining vigilant on costs while ensuring we continue to invest in areas key to fulfilling our growth ambitions. Longer-term, our value proposition remains as compelling as ever, and we remain focused on cementing our position as one of the leading providers of privileged access security."

 

Contacts

 

 

 

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

 

Rupert Hutton, CFO

 

 

 

Stifel Nicolaus Europe Limited

Tel: +44 (0)20 7710 7600

Fred Walsh

 

 

 

Alma PR (financial PR adviser)

Tel: +44 (0)20 3405 0205

Josh Royston

osirium@almapr.co.uk

David Ison

 

Kieran Breheny

 

 

 

About Osirium

 

Osirium Technologies plc (AIM: OSI) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Security solutions. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.

 

Osirium has defined and delivered what the Directors view as the next generation Privileged Access Management solution. Osirium's award-winning Privileged Task Management module further strengthens Privileged Account Security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers. Building on Osirium's Privileged Task Management module, in May 2019 Osirium launched Privileged Process Automation, providing a highly-flexible platform for automating essential IT processes to set a new benchmark in IT Process Automation. This was followed by the launch of Privileged Endpoint Manager in December 2019, bringing the total portfolio to three complementary solutions.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016.

 

www.osirum.com

 

 

 

Chief Executive Officer's Review

 

Driven by a growing awareness in the market of privileged access security as a business-critical issue and underpinned by the investment we have made in our products and operations, we achieved our best ever first quarter for bookings, successfully secured a number of significant new customers across different sectors and geographies and maintained our 100% customer retention rate in the half, with renewals across our existing base. 

 

As with most UK businesses, we were not immune to the effects of the coronavirus outbreak at the end of the first quarter. Because of the widespread uncertainty caused by the pandemic in the second quarter, we saw temporarily reduced appetite from potential new customers whose priorities had shifted. Encouragingly, though, since period end, impetus in conversations with prospective customers has begun to return.

 

While the pandemic had an impact on the timing of bookings in the first half of FY2020, it should not detract from the significant progress we have continued to make as a business. We have retained all our customers, our pipeline has continued to grow, our product suite has gone from strength to strength, our reseller network has grown substantially, and our marketing function has shown itself to be capable of pivoting from events-based to online lead generation smoothly and effectively.

 

Coronavirus response

 

As previously reported, our top priority since the outbreak of the pandemic has been to protect our colleagues, customers and other stakeholders. We also took immediate action to protect our financial position, putting a temporary freeze on new recruitment. Encouragingly, the COVID-19 pandemic has led to the introduction of long-standing business continuity measures, which will continue to evolve and stand the business in good stead for years to come. The response of our colleagues to the new ways of working has been first-class. They remain active and engaged and we are fortunate enough to have not had to make any additional cuts, make use of any government financial support schemes or furlough any members of staff.

 

Market

 

In recent years, Privileged Access Management (PAM), has become one of the fastest growing areas of cyber security and risk management software solutions. KuppingerCole, the international technology research organisation, estimates the market is worth revenue of around $2.2bn per annum predicted to grow to $5.4bn by 2025 (Kuppinger Cole Leadership Compass, Privileged Access Management, March 2020).

 

The automation market, where our Privileged Process Automation offering is well positioned to compete, is seeing similar strong growth. According to Mordor Intelligence, the digital process automation market is expected to grow from $7.8 billion in 2019 to reach a value of $16.12 billion by 2025 (Mordor Intelligence, Digital Process Automation Market Size - Growth, Trends and Forecast (2020-2025), 2019)

 

 

 

Product development

 

Across our portfolio, we have been focused on incremental improvements that enhance the user experience and add security and value to customers. One example of this is the shift to a new web user interface for our flagship Privileged Access Management Platform.

 

Moving forwards, we remain focused on optimising our product suite while exploring new and innovative ways to penetrate our target markets. One of these is introducing free downloads to generate new leads. Building on the success of the free PAM Express, in early September we released PPA Express, a free version of our Privileged Process Automation platform.

 

Partner and reseller network expansion

 

Against the backdrop of the COVID-19 pandemic, we have accelerated our efforts to take advantage of opportunities outside the UK, in continental Europe and the Middle East. Our reseller channel expanded significantly in the period with 13 new partners signed up, as the market becomes more aware of Privileged Access Management and Osirium's competitive advantage. Establishing and deepening these relationships with reseller and cloud partners remains a primary strategic objective in positioning the Group for scalable growth, and our position in the market means we can execute more quickly and effectively than some of our larger peers.

 

There are multiple prospects emerging across the network, which now spans several territories including Benelux, the Nordics, South-eastern Europe and the Middle East. While the business continues to achieve a significant proportion of contracted revenue through direct sales, there is starting to be a shift toward resellers. The Group expects over time to increase the contribution of partner channel sales.

 

We also continue to make good progress in forming strategic technology alliances. These alliances strengthen our market position by expanding the range of complementary technologies with which we integrate, opening up new market opportunities, and embedding our technology more tightly in customer environments. Post period, we agreed partnerships with cybersecurity and network management firm AppViewX, cyber security and digital risk management company RSA, and identity and access management company My1Login. We continue to seek new opportunities to team up with like-minded organisations.

 

In the period we also launched the Osirium Customer Network, a forum for existing customers to meet and share best practices and experiences with Osirium Technology. Online workshops on topics such as securing 3rd party access have been received particularly positively, with the first events at full capacity. The Customer Network strengthens our relationship with our customers as well as helping them maximise the value they gain from their investment in Osirium.

 

Current trading and outlook

 

We continued to make good progress against our stated strategy in the period, built around a commitment to innovation, customer focus and market expansion. The coronavirus temporarily slowed new customer acquisition after a record Q1, but market trends continue to move in our favour. We now have a comprehensive and complementary suite of products designed to capitalise on the opportunity, and our pipeline continues to grow.

 

While the impact of the coronavirus on the timing of new customer buying decisions means revenue for FY2020 may be lower than current market estimates, the strength of our offering and our growing pipeline provide a strong platform and give us confidence that, assuming the heightened level of uncertainty caused by the virus continues to subside, we will see an uptick in new business wins in the second half and increased revenue growth in FY2021.

 

Moving forwards, we remain focused on delivering our strategic objectives. Management will continue to closely monitor both the financial and operational effects of pandemic on the business, remaining vigilant on costs while ensuring we continue to invest in areas key to fulfilling our growth ambitions. Longer-term, our value proposition remains as compelling as ever, and we remain focused on cementing our position as one of the leading providers of privileged access security.

 

 

 

Chief Financial Officer's Review

 

Bookings were ahead of management expectations to the end of March and into April. However, as the magnitude of the pandemic became clearer, we began to see indications that prospective customers were deferring IT project-related decisions in favour of focusing on business continuity and cost control to mitigate business and commercial threats posed by the virus. With new customer acquisition slowing in Q2, bookings for the half were £0.77 million, a 25% decrease on £1.03m in the corresponding period in the previous year.

 

The year-on-year bookings shortfall also reflects the fact that our business signed a substantial three-year contract with one of our key customers in the first half of 2019 that was not repeatable. While that customer has continued to take services from us throughout the first half of this fiscal year, the difference in value versus the original SaaS contract was significant. Excluding this customer, bookings for H1 2020 would have been comfortably ahead of H1 2019, with the majority of existing customers booking more in the first half of this year than last.

 

Revenue was £0.70 million, a 35% increase from £0.52 million in the corresponding period last year and ahead of management expectations due to the timing of bookings and the mix of one and three-year contracts. Deferred revenue as at 30 June 2020 was £1.43 million, a 15% increase from £1.24 million as at 30 June 2019, providing continued visibility over future revenues.

 

Osirium's operating loss was £1.57 million versus £1.71 million in the first half of the previous financial year, reflecting the tight cost control measures that were introduced in response to the coronavirus while continuing our investment in R&D, sales and marketing as the cornerstones of our growth strategy. We will continue to closely monitor and control costs in the second half, while maintaining our commitment to investing for sustainable long-term growth. Loss before tax for the period was £1.68 million versus £1.71m million in the first half of the previous financial year, including a new loan note interest that was not incurred in the previous year.

 

Cash balances were £2.13 million at the end of the period under review (H1 2019: £0.89 million). Post period, the Group received R&D tax credit of £0.56 million, resulting in a £2.53 million cash balance as of 31 July 2020. 

 

Product development expenditure capitalised in the period was £0.78 million (H1 2019: 0.87 million). All of this expenditure was associated with new products and features.

 

Our headcount was 58 as at 30 June 2020 (June 2019: 50). Headcount increases in the period were principally in Sales and Marketing and Engineering as we added capacity to develop new products and service our partner channel.

 

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

 

 

 

6 months to

 

6 months to

 

Year to

 

 

 

 

 

30-Jun-20

 

30-Jun-19

 

31-Dec-19

 

 

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

 

 

£

 

£

 

£

CONTINUING OPERATIONS

 

 

 

 

 

 

 

Revenue

 

 

 

 

702,649

 

515,450

 

1,171,586

Other operating income

 

 

700

 

-

 

-

Administrative expenses

 

 

(2,271,996)

 

(2,225,090)

 

(4,571,317)

 

 

 

 

 

 

 

 

 

 

OPERATING LOSS

 

 

 

(1,568,647)

 

(1,709,640)

 

(3,399,731)

Finance costs

 

 

 

(110,875)

 

(367)

 

(52,197)

Finance income

 

 

 

-

 

15

 

35

 

 

 

 

 

 

 

 

 

 

LOSS BEFORE TAX

 

 

 

(1,679,522)

 

(1,709,992)

 

(3,451,893)

Income tax credit

 

 

 

260,654

 

334,262

 

622,514

 

 

 

 

 

 

 

 

 

 

LOSS FOR THE PERIOD ATTRIBUTABLE TO

 

 

 

 

 

 

THE OWNERS OF OSIRIUM TECHNOLOGIES PLC

(1,418,868)

 

(1,375,730)

 

(2,829,379)

 

 

 

 

 

 

 

 

 

 

Loss per share from continuing operations:

7p

 

10p

 

19p

Basic and diluted loss per share

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

 

 

 

 

30-Jun-20

 

30-Jun-19

 

31-Dec-19

 

 

 

 

 

(Unaudited)

 

(Unaudited)

 

(Audited)

 

 

 

 

 

£

 

£

 

£

ASSETS

 

 

 

 

 

 

 

 

 

NON-CURRENT ASSETS

 

 

 

 

 

 

 

Intangible assets

 

 

 

3,101,660

 

2,691,314

 

2,936,473

Property, plant & equipment

 

 

76,027

 

81,673

 

77,534

Right-of-use asset

 

 

 

85,861

 

-

 

110,392

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

 

 

Trade and other receivables

 

 

1,194,099

 

1,152,232

 

982,369

Cash and cash equivalents

 

 

2,128,347

 

889,600

 

3,854,922

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,322,446

 

2,041,832

 

4,837,291

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

 

 

6,585,994

 

4,814,819

 

7,961,690

 

 

 

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

Trade and other payables

 

 

1,836,258

 

1,866,065

 

1,889,098

Lease liability

 

 

 

33,916

 

-

 

33,916

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,870,174

 

1,866,065

 

1,923,014

NON-CURRENT LIABILITIES

 

 

 

 

 

 

 

Lease liability

 

 

 

68,578

 

-

 

76,973

Convertible loan notes

 

 

2,449,815

 

-

 

2,345,408

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,518,393

 

-

 

2,422,381

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

 

4,388,567

 

1,866,065

 

4,345,395

 

 

 

 

 

 

 

 

 

 

EQUITY

 

 

 

 

 

 

 

 

 

SHAREHOLDERS EQUITY

 

 

 

 

 

 

 

Called up share capital

 

 

194,956

 

135,542

 

194,956

Share premium

 

 

 

10,635,500

 

8,968,554

 

10,635,500

Share option reserve

 

 

337,559

 

337,559

 

337,559

Convertible note reserve

 

 

394,830

 

-

 

394,830

Merger reserve

 

 

 

4,008,592

 

4,008,592

 

4,008,592

Retained earnings

 

 

 

(13,374,010)

 

(10,501,493)

 

(11,955,142)

 

 

 

 

 

 

 

 

 

 

TOTAL EQUITY ATTRIBUTABLE TO THE

 

 

 

 

 

 

OWNERS OF OSRIRIUM TECHNOLOGIES PLC

2,197,427

 

2,948,754

 

3,616,295

 

 

 

 

 

 

 

 

 

 

TOTAL EQUITY AND LIABILITIES

 

6,585,994

 

4,814,819

 

7,961,690

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Attributable to the owners of Osirium Technologies plc

 

 

 

Called up

 

 

 

 

 

 

 

Share

 

Convertible

 

 

 

 

 

share

 

Retained

 

Share

 

Merger

 

option

 

note

 

Total

 

 

 

capital

 

earnings

 

premium

 

reserve

 

reserve

 

reserve

 

equity

 

 

 

£

 

£

 

£

 

£

 

£

 

£

 

£

Balance at 1 January 2019

135,542

 

(9,125,763)

 

8,968,554

 

4,008,592

 

337,559

 

-

 

4,324,484

Changes in equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss

-

 

(1,375,730)

 

-

 

-

 

-

 

-

 

(1,375,730)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 June 2019 (unaudited)

135,542

 

(10,501,493)

 

8,968,554

 

4,008,592

 

337,559

 

-

 

2,948,754

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2019

135,542

 

(9,125,763)

 

8,968,554

 

4,008,592

 

337,559

 

-

 

4,324,484

Issue of share capital

 

59,414

 

-

 

2,020,091

 

-

 

-

 

-

 

2,079,505

Issue costs

 

-

 

-

 

(353,145)

 

-

 

-

 

-

 

(353,145)

Equity element of loan notes issued

-

 

-

 

-

 

-

 

-

 

394,830

 

394,830

Total comprehensive loss

-

 

(2,829,379)

 

-

 

-

 

-

 

-

 

(2,829,379)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2019 (audited)

194,956

 

(11,955,142)

 

10,635,500

 

4,008,592

 

337,559

 

394,830

 

3,616,295

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2020

194,956

 

(11,955,142)

 

10,635,500

 

4,008,592

 

337,559

 

394,830

 

3,616,295

Changes in equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss

-

 

(1,418,868)

 

-

 

-

 

-

 

-

 

(1,418,868)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 30 June 2020 (unaudited)

194,956

 

(13,374,010)

 

10,635,500

 

4,008,592

 

337,559

 

394,830

 

2,197,427

 

  

CONSOLIDATED STATEMENT OF CASHFLOWS

 

 

 

 

 

 

6 months

 

6 months

 

Year

 

 

 

 

 

ended

 

ended

 

ended

 

 

 

 

 

30-Jun-20

 

30-Jun-19

 

31-Dec-19

 

 

 

 

 

(unaudited)

(unaudited)

(audited)

 

 

 

 

 

£

 

£

 

£

Cashflows from operating activities

 

 

 

 

 

 

Cash used in operations

 

 

(905,478)

 

(569,568)

 

(1,517,218)

Interest paid

 

 

 

-

 

(367)

 

-

Tax received

 

 

 

-

 

-

 

472,076

 

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

(905,478)

 

(569,935)

 

(1,045,142)

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

Purchase of intangible fixed assets

 

(781,570)

 

(872,670)

 

(1,773,395)

Purchase of tangible fixed assets

 

(25,152)

 

(54,434)

 

(79,428)

Sale of tangible fixed assets

 

 

-

 

-

 

431

Interest received

 

 

 

-

 

15

 

35

 

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

(806,722)

 

(927,089)

 

(1,852,357)

 

 

 

 

 

 

 

 

 

 

Cashflows from financing activities

 

 

 

 

 

 

Share issue

 

 

 

-

 

-

 

2,079,505

Share issue costs

 

 

 

-

 

-

 

(353,145)

Issue of loan notes

 

 

 

-

 

-

 

2,700,000

Lease payment

 

 

 

(14,375)

 

-

 

(60,563)

 

 

 

 

 

 

 

 

 

 

Net cash from financing activities

 

(14,375)

 

-

 

4,365,797

 

 

 

 

 

 

 

 

 

 

Increase/(decrease) in cash and cash equivalents

(1,726,575)

 

(1,497,024)

 

1,468,298

Cash and cash equivalents at beginning of period

3,854,922

 

2,386,624

 

2,386,624

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

2,128,347

 

889,600

 

3,854,922

 

 

 

GENERAL INFORMATION

Osirium Technologies PLC was incorporated on 3 November 2015, and registered and domiciled in England and Wales with its registered office located at One Central Square, Cardiff CF10 1FS.

 

The principal activity of the Group in the periods under review was that of the development of security software.

 

BASIS OF PREPARATION AND SIGNIFICANT ACCOUNTING POLICIES

 

Basis of preparation

 

The Group financial information is presented in pounds sterling which is the Group's presentational currency and all values are rounded to the nearest whole pound.

 

The financial information does not comprise statutory accounts within the meaning of section 435 of the Companies Act 2006. The financial information together with the comparative information for the six months ended 30 June 2019 are unaudited with the audited information included for the 12 month period ended 31 December 2019. The audited information received an audit report which was unqualified and did not include a statement under section 498(2) or section 498(3) of the Companies Act 2006.

 

The financial information was approved by the Board of Directors on 28 September 2020 and authorised for issue on 29 September 2020.

 

Accounting Policies

 

The accounting policies used in the preparation of the financial information for the six months ended 30 June 2020 are in accordance with the recognition and measurement criteria of the International Financial Reporting

Standards as adopted by the European Union ('IFRS') and are consistent with those which will be adopted in the annual financial statements for year ending 31 December 2020.

 

These Interim Financial Statements have been prepared in accordance with the accounting policies, methods of computation and presentation adopted in the financial statements for the year ended 31 December 2019.

 

The Directors have considered all new, revised or amended standards and interpretations which are mandatory for the first time for the financial year ending 31 December 2020, and concluded that none have had any significant impact on these interim financial statements. New, revised or amended standards and interpretations that are not yet effective have not been adopted early.

 

Going concern

As part of their going concern review the Directors have followed the guidelines published by the Financial Reporting Council entitled "Guidance on the Going Concern Basis of Accounting and Reporting on Solvency and Liquidity Risks (2016)". The Directors have prepared detailed financial forecasts and cash flows looking beyond 12 months from the date of these Interim Statements. In developing these forecasts the Directors have made assumptions based upon their view of the current and future economic conditions that will prevail over the forecast period.

 

On the basis of the above projections, the Directors are confident that Osirium has sufficient working capital to honour all of its obligations to creditors as and when they fall due. Accordingly, the Directors continue to adopt the going concern basis in preparing the Financial Statements.

 

Cash reserves were boosted by the fund raise in the year to 31 December 2019 that raised £4.4m net cash in October 2019.

 

As at the end of the interim period ended 30 June 2020 the group had cash reserves of £2.1 million cash at bank available to support future business activities, post period end, the Group has received a R&D tax credit of £0.56 million, and the Group had £2.53 million cash as of 31 July 2020

 

The Board remains cautious and vigilant in the very short-term, as the full impact of COVID-19 on the general economy is not yet known. However we have contingency plans in place and have factored this into our business planning to the best of our ability. Given the Group's high level of recurring revenue, strong backlog of contracted future revenue, and software offering that supports mission critical operations, the Board believes the business to be well positioned to withstand this period and has confidence in the Group's ongoing momentum.

 

Intangible assets

 

An internally-generated, development intangible asset arising from Osirium's product development is recognised if, and only if, Osirium can demonstrate all of the following:

- The technical feasibility of completing the intangible asset so that is will be available for use of sale.

- Its intention to complete the intangible asset and use or sell it.

- Its ability to use or sell the intangible asset.

- How the intangible asset will generate probable future economic benefits.

- The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.

- Its ability to measure reliably the expenditure attributable to the intangible asset during its development.

Internally-generated development intangible assets are amortised on a straight-line basis over their useful lives. Amortisation commences in the financial year of capitalisation. Where no internally-generated intangible asset can be recognised, development expenditure is recognised as an expense in the period in which it is incurred.

 

Development costs 20% per annum, straight line.

 

Share based payments

 

Osirium issues equity-settled share-based payments to certain employees and others under which Osirium receives services as consideration for equity instruments (options) in Osirium. Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted. The fair value determined at the grant date of equity-settled share-based payments is recognised as an expense in Osirium's Statement of Comprehensive Income over the vesting period on a straight-line basis, based on Osirium's estimate of the number of instruments that will eventually vest with a corresponding adjustment to equity. The expected life used in the valuation is adjusted, based on management's best estimate, for the effect of non-transferability, exercise restrictions, and behavioural considerations.

 

Non-vesting and market vesting conditions are taken into account when estimating the fair value of the options at grant date. Service and non-market vesting conditions are taken into account by adjusting the number of options expected to vest at each reporting date. When the options are exercised Osirium issues new shares. The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium.

 

 

INTANGIBLE FIXED ASSETS

 

 

 

 

 

 

Development

 

 

 

 

 

Costs

 

 

 

 

 

£

Cost

 

 

 

 

 

At 1 January 2019

 

 

 

5,919,434

Additions to 30 June 2019

 

 

872,670

Cost c/f as at 30 June 2019

 

 

6,792,104

 

 

 

 

 

 

At 1 January 2019

 

 

 

5,919,434

Additions to 31 December 2019

 

1,773,395

Cost c/f as at 31 December 2019

 

7,692,829

 

 

 

 

 

 

At 1 January 2020

 

 

 

7,692,829

Additions to 30 June 2020

 

 

781,570

Cost c/f as at 30 June 2020

 

 

8,474,399

 

 

 

 

 

 

Amortisation

 

 

 

 

At 1 January 2019

 

 

 

3,612,199

Charge to 30 June 2019

 

 

488,591

Amortisation c/f as at 30 June 2019

 

4,100,790

 

 

 

 

 

 

At 1 January 2019

 

 

 

3,612,199

Charge to 31 December 2019

 

 

1,144,157

Amortisation c/f as at 31 December 2019

 

4,756,356

 

 

 

 

 

 

At January 2020

 

 

 

4,756,356

Charge to 30 June 2020

 

 

616,383

Amortisation as at 30 June 2020

 

5,372,739

 

 

 

 

 

 

Carrying Amount:

 

 

 

 

 

 

 

 

 

 

At 30 June 2019 (unaudited)

 

 

2,691,314

 

 

 

 

 

 

At 31 December 2019 (audited)

 

2,936,473

 

 

 

 

 

 

At 30 June 2020 (unaudited)

 

 

3,101,660

 

All development costs are amortised over their estimated useful lives, which is on average 5 years. Amortisation is charged in full in the financial year of capitalisation.

 

All amortisation has been charged to the administrative expenses in the statement of comprehensive income and total comprehensive loss.

 

 

 

 

RIGHT OF USE ASSETS

 

 

 

 

Leases & Buildings

 

 

 

 

£

Cost

 

 

 

 

At 31 December 2018

 

 

-

Additions

 

 

 

159,455

At 31 December 2019

 

 

159,455

Additions

 

 

 

-

At 30 June 2020

 

 

159,455

 

 

 

 

 

Depreciation

 

 

 

At 31 December 2018

 

 

-

Charge for year

 

 

49,063

At 31 December 2019

 

 

49,063

Charge for year

 

 

24,531

At 30 June 2020

 

 

73,594

 

 

 

 

 

Net Book Value

 

 

 

At 31 December 2019

 

 

110,392

 

 

 

 

 

At 30 June 2020

 

 

85,861

 

Additions to the right-of-use assets during the period were £nil (year to 31 December 2019: £159,455).

 

The group leases land and buildings for its office under an agreement for 4 years running from 2018 to 2022.

 

LEASE LIABILITIES

 

 

 

Group

 

 

 

As at

 

As at

 

 

 

30-Jun-20

 

31-Dec-19

 

 

 

£

 

£

Current

 

 

 

 

 

Lease liability

 

33,916

 

33,916

 

 

 

 

 

 

Non- current

 

 

 

 

Lease liability

 

68,578

 

76,973

 

 

RECONCILIATION OF LOSS BEFORE ANY INCOME TAX TO CASH GENERATED FROM OPERATIONS

 

 

 

 

 

 

6 months

 

6 months

 

Year

 

 

 

 

 

ended

 

ended

 

ended

 

 

 

 

 

30-Jun-20 (unaudited)

 

30-Jun-19 (unaudited)

 

31/12/19 (audited)

 

 

 

 

 

£

 

£

 

£

Loss before income tax

 

 

(1,679,522)

 

(1,709,992)

 

(3,451,893)

Depreciation charges

 

 

51,190

 

25,681

 

103,446

Amortisation charges

 

 

616,383

 

488,591

 

1,144,157

Finance costs

 

 

 

110,875

 

367

 

52,197

Finance income

 

 

 

-

 

(15)

 

(35)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(901,074)

 

(1,195,368)

 

(2,152,127)

(Increase)/decrease in trade and other receivables

50,138

 

(69,959)

 

(83,883)

Increase /(decrease) in trade and other payables

(54,542)

 

695,759

 

718,792

 

 

 

 

 

 

 

 

 

 

Cash used in operations

 

 

(905,478)

 

(569,568)

 

(1,517,218)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com .

 

End

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR VVLFLBKLBBBF
Date   Source Headline
31st Oct 20237:00 amRNSCancellation - Osirium Technologies plc
30th Oct 202310:39 amRNSSCHEME OF ARRANGEMENT BECOMES EFFECTIVE
30th Oct 20237:30 amRNSSuspension - Osirium Technologies plc
26th Oct 202311:22 amRNSCourt Sanction of Scheme of Arrangement
12th Oct 20233:09 pmRNSResults of Court Meeting and General Meeting
28th Sep 20234:33 pmRNSForm 8.3 - Osirium Technologies plc
27th Sep 20231:36 pmRNSForm 8.3 - Osirium Technologies plc
18th Sep 20237:00 amRNSPublication and Posting of Scheme Document
14th Sep 20231:34 pmRNSForm 8.3 - Osirium Technologies PLC
8th Sep 20232:08 pmRNSForm 8.3 - Osirium Technologies plc
7th Sep 20234:09 pmRNSForm 8.3 - Osirium Technologies plc
7th Sep 20237:00 amRNSInterim Results
5th Sep 20233:14 pmGNWCorrection: Form 8.3 - Octopus Investments - Osirium Technologies plc
5th Sep 20237:00 amRNSForm 8 (OPD) Osirium Technologies plc
1st Sep 20234:58 pmRNSForm 8.3 - Osirium Technologies plc
1st Sep 202311:10 amRNSForm 8.3 - Osirium Technologies plc- Amendment
31st Aug 20234:24 pmRNSForm 8.3 - Osirium Technologies PLC
31st Aug 20232:02 pmGNWForm 8.3 - Osirium Technologies plc
31st Aug 202311:28 amRNSForm 8.3 - Osirium Technologies plc
31st Aug 202310:51 amRNSForm 8.3 - Osirium Technologies plc
31st Aug 20239:50 amRNSForm 8 (DD) - Osirium Technologies plc
30th Aug 202312:00 pmRNSRecommended Acquisition of Osirium Technologies
18th Jul 20237:00 amRNSHalf Year Trading Update
13th Jun 20237:00 amRNSAttendance at InfoSec Europe 2023
22nd May 20237:00 amRNSGrant of Options and PDMR Dealings
9th May 202312:40 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Statement and Q1 trading update
18th Apr 20237:00 amRNSUpdate re proposed grant of options
3rd Apr 20237:00 amRNSNotice of AGM & Proposed Changes to Option Scheme
24th Mar 20234:40 pmRNSSecond Price Monitoring Extn
24th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20237:00 amRNSFinal Results
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20239:00 amRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSFull Year Trading Update
4th Jan 202311:59 amRNSHolding(s) in Company
3rd Jan 20237:00 amRNSConfirmation of Board Changes
30th Dec 20227:00 amRNSTotal Voting Rights
19th Dec 202210:30 amRNSHoldings in Company
15th Dec 202211:51 amRNSHolding(s) in Company
15th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20222:25 pmRNSHolding(s) in Company
12th Dec 202210:19 amRNSResult of General Meeting
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:12 pmRNSTR-1: Notification of Major Holdings
28th Nov 20223:11 pmRNSTR-1: Notification of Major Holdings
28th Nov 20223:10 pmRNSTR-1: Notification of Major Holdings
22nd Nov 20227:00 amRNSProposed Placing, Subscription, Board Changes & GM
1st Nov 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.